作者:国际循环网 发布于:2004-08-06
BACKGROUND: The efficacy of antihypertensive drugs newer than diuretics and beta-blockers has not been established. We compared the effects of the calcium-chann...
作者:BrownMJ,PalmerCR 发布于:2004-08-06
OBJECTIVE: Irbesartan is renoprotective in patients with type 2 diabetes and microalbuminuria. Whether the observed reduction in microalbuminuria is reversible ...
The Japan Multicenter Investigation for Cardiovascular Diseases-B was performed to investigate whether nifedipine retard treatment was associated with a signifi...
BACKGROUND: Blood pressure reduction achieved with beta-blockers and diuretics is the best recorded intervention to date for prevention of cardiovascular morbid...
BACKGROUND: Elevated urine albumin excretion (UAER) is a modifiable risk factor for renal and cardiovascular disease in type 2 diabetes. Blockade of the renin-a...
BACKGROUND: Earlier angiographic studies have suggested that calcium antagonists may prevent the formation of new coronary lesions and the progression of minima...
作者:Leuven,Belgium 发布于:2004-08-06
We investigated the effect of long-term treatment with a calcium antagonist (nicardipine hydrochloride retard tablet) and a diuretic (trichlormethiazide) on qua...
BACKGROUND: Calcium antagonists are a first-line treatment for hypertension. The effectiveness of diltiazem, a non-dihydropyridine calcium antagonist, in redu...
Gosse P, Dubourg O, Gueret P, De Simone G, Schmieder R, De Leeuw PW, Degaute JP, Garcia Puig J, Karpov Y, Magometschnigg D, Matos L, Amouyel P, Asma...
专家视角丨高血压管理新篇:余静教授202..
心房颤动患者和动脉粥样硬化患者磁共振..
ESC专访|郭豫涛教授解析mAFA扩展试验结..
波兰国家注册数据:药物涂层球囊治疗冠..